Los Angeles – September 15, 2026 -- Partillion Bioscience has secured a two-year, $2.1 million NIH Small Business Innovation Research (SBIR) award to scale its Cell-Cell-seq technology toward datasets of up to one million cell pairs. The grant, awarded by the National Institute of General Medical Sciences (NIGMS) under Award Number R44GM165220, is Partillion's 10th SBIR grant and brings the company's total non-dilutive federal funding past $8 million, roughly matching its private investment to date without additional equity dilution.
